Vaxil Bio Ltd.

Vaxil Bio Ltd.

Vaxil Bio Ltd.

Overview
Date Founded

2013

Headquarters

First Canadian Place,100 King Street West,34th Floor,Toronto, ON M5X 1A9

Type of Company

Public

Industries

Biotechnology
Metal Manufacturing & Products

Company Description

Vaxil Bio Ltd. engages in the development of immunotherapies such as neoantigen-like peptide products, and antibodies to treat cancer and infectious diseases. Its pipeline consists of ImMucin, SPmAb2, SPmAb6, and MTbuVax. The company was founded on September 13, 2013 and is headquartered in Toronto, Canada.

Executives & Employees

Chairman & Chief Executive Officer

Chief Financial Officer & Director

Chief Medical Officer

Director

Board of Directors

Chairman & Chief Executive Officer at Vaxil Bio Ltd.

Executive Director, Finance Director at Eco (Atlantic) Oil & Gas Ltd.

Chief Executive Officer at Solta Medical, Inc.

Director at Vaxil Bio Ltd.

Member, Board of Directors at Théraclion SA

Paths to Vaxil Bio Ltd.
Potential Connections via
Relationship Science
You
Vaxil Bio Ltd.
Recent Transactions
Details Hidden

Emerge Resources Corp. purchases Vaxil Bio Ltd. (Inactive) resulting in a new company Vaxil Bio Ltd.

Key Stats and Financials As of 2018
Market Capitalization
$6.38M
Total Enterprise Value
$1.85M
Earnings Per Share
$-0.01
Debt TEV
0.03x
TEVNet Income
-1.77x
Total Equity
$435K
Total Debt
$49K
EBITDA
$-985K
Net Profit
$-1.05M
Revenue
$0
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Vaxil Bio Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Vaxil Bio Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Vaxil Bio Ltd..